Durability of Triple Combination Therapy Versus Stepwise Addition Therapy in Patients With New-Onset T2DM: 3-Year Follow-up of EDICT

Lignende værker

• Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add-on therapy in subjects with new-onset diabetes. Results from the Efficacy and Durability of Initial Combination Therapy for Type 2 Diabetes (EDICT): a randomized trial
  af: Abdul-Ghani, M. A., et al.
  Udgivet: (2015)
• Insulin Secretion is a Strong Predictor for Need of Insulin Therapy in Patients With New Onset Diabetes and HbA1c >10%, a post hoc analysis of EDICT study
  af: Abdelgani, S, et al.
  Udgivet: (2021)
• Combination Therapy With Canagliflozin Plus Liraglutide Exerts Additive Effect on Weight Loss, but Not on HbA(1c), in Patients With Type 2 Diabetes
  af: Ali, Ali Muhammed, et al.
  Udgivet: (2020)
• Pioglitazone and alogliptin combination therapy in type 2 diabetes: a pathophysiologically sound treatment
  af: Triplitt, Curtis, et al.
  Udgivet: (2010)
• Clinical Parameters, Fuel Oxidation, and Glucose Kinetics in Patients With Type 2 Diabetes Treated With Dapagliflozin Plus Saxagliptin
  af: Qin, Yuejuan, et al.
  Udgivet: (2020)